Caricamento...
Treatment of genotype 2 and 3 chronic hepatitis C virus-infected patients
AIM: Before pegylated interferon alpha (IFN) was introduced for the therapy of chronic hepatitis C virus (HCV)-induced hepatitis, conventional thrice weekly IFN therapy was supplemented by ribavirin. Also, at that time, higher and more frequent doses of IFN were expected to be more effective than th...
Salvato in:
| Pubblicato in: | World J Gastroenterol |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Baishideng Publishing Group Inc
2005
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4436638/ https://ncbi.nlm.nih.gov/pubmed/16273648 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v11.i39.6188 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|